Question: Two affiliates of a hugely successful hedge fund, SAC Capital Advisors, were charged with insider trading by the SEC. CR Intrinsic Investors and Sigma Capital Management apparently relied on expert networks where, allegedly, people with information funnel it to traders. The biggest charge centered on a doctor who had passed on information to a trader regarding problems with a new drug that targeted Alzheimer's disease. After such information, around $1 billion shares of two pharmaceutical companies related to the drug were sold before the drug information was ever released to the public. The drug was still going through scientific trials, and the results had not even been finalized. The doctor was part of that project. How do you think this case turned out?